A case is described of a roentgenographically confirmed primary suprasellar tumour in a 14 year old Negro boy, who presented with the clinical and laboratory findings of Cushing's syndrome, together with hyperpigmentation, homonymous hemianopia and unilateral ptosis. This appears to be the youngest case exhibiting Cushing's sydrome secondary to this aetiology, and one of a small number in whom the tumour could be well delineated roentgenographically in the presence of an essentially normal sella. The significant endocrine abnormalities were the demonstration of increased plasma corticotrophin levels, and the failure of both pituitary suppression by dexamethasone and of adrenal stimulation by corticotrophin. The tumour was extremely sensitive to 4500 r 60Co therapy. The remission produced thus far is of two years duration.
Recently there have been a number of reports of cases with Cushing's syn¬ drome occurring in association with pituitary tumours. In many of these (Nelson et al. 1958; Salassa et (Cohen et al. 1960 ; Nymes 8c Doe 1962), pancreas (Rosenberg 1956; Bail et al. 1959) , thymus (Hubble 1949; Scholz 8c Bahn 1959), ovary (Parsons Sc Rigby 1958; Nichols et al. 1962) , and miscel¬ laneous tumours (Webster et al. 1959; Bornstein et al. 1961; Allott Sc Skelton 1960; Riggs Sc Sprague 1961; Levine Sc Smith 1960; Brickner et al. 1961) , an increased production of corticotrophin-like material by the primary tumour has been postulated (Bornstein et al. 1961; Levine Se Smith 1960) or demon¬ strated (Nichols et al. 1962; Meador et al. 1962; Vance et al. 1962; Liddle et al. 1963 ).
The present study describes the youngest subject thus far reported with Cushing's syndrome secondary to a suprasellar lesion. Hyperpigmentation and visual symptoms accompanied the physical manifestations of Cushing's syn¬ drome. Increased plasma levels of corticotrophin were demonstrated which declined following irradiation of the lesion.
METHODS
Plasma 17-hydroxycorticosteroids were determined by a modification of the Petersen method (Petersen et al. (1957) . Urine 17-OH corticosteroids were determined by a modification of the Porter-Silber method (Silber Se Porter 1954) . Urinary 17-keto¬ steroid assays were performed by a modification of the Drekter method (Drekter et al. 1962) . Urinary aldosterone determinations were performed by a modification of the method of Sobel (Sobel et al. 1959) . Serum serotonin determinations and urinary 5-hydroxyindoleacetic acid levels were determined by modification of Udenfriend's methods Fig. 1 A) The electroencephalogram was normal. X-ray studies of the skull showed a normal sella turcica (Fig. 4) , except for lack of complete visualization of the right anterior clinoid process. Tomography revealed the floor of the sella turcica to be somewhat lower on the right than on the left, and once again the right anterior clinoid process was not well visualized. Pneumoencephalography showed the inferior portion of the anterior third ventricle to be truncated. (Fig. 5) . The floor of the ventricle, the (Soffer Se Gabrilove 1952) produced a diuresis of only 600 ml 5 hours after the administration of 1500 ml H20 p. o., whereas when this test was repeated follow¬ ing the administration of 50 mg of cortisone, 1150 ml were excreted. Thyroid function studies at this time were within the normal range (Table 1) .
Ten weeks after admission (and 1 month after all therapy had been completed), the patient had lost 9.07 kg, and iacial rounding had completely disappeared (Fig.  1 B) . Visual Cortisone was discontinued 10 months after his initial admission, the patient having been on steroid therapy for seven months. He has been able to attend school and maintain satisfactory grades. His weight, pigmentation and blood pressure have been stable. Visual fields 7 months after discharge showed a persistent right homonymous hemianopsia ( Fig. 2 and C) . Despite this, the patient has no visual symptoms.
Recent X-rays of the spine show evidence of remineralization. A second PEG performed 6 weeks after completion of radiotherapy showed a marked decrease in the size of the mass below the third ventricle (Fig. 5B) .
Ten months after his initial admission a third pneumoencephalogram showed no change in the suprasellar mass as compared to its size after completion of radio¬ therapy. Skull X-rays at this time were similar to those taken on admission (Fig. 4) Cushing's (1932) (Montgomery et al. 1959) , the pathology of the pituitary tumour has been that of an adenoma, usually chromophobe in character, although one instance of a basophilic adenoma has been reported (Rees 8c Bayliss 1959). In some of the »secondary« cases a pituitary tumour may have been present before adrenalectomy, although not reflected in an increase in the size of the sella. Its subsequent growth might then follow adrenalectomy as a result of the loss of the »cortisone feed back mechanism« that was operative when the adrenals were still present.
The present case falls into the category described as »Cushing's syndrome associated with primary pituitary tumour«. This diagnosis was established in the absence of histological confirmation for the following reasons: 1. the com¬ bination of the features of Cushing's syndrome associated with hyperpig¬ mentation (pointing to an extra-adrenal source of the syndrome). 2. the presence of oculomotor and visual involvement (indicating intracranial in¬ volvement), and 3. the X-ray findings of some irregularity in the floor of the sella together with the pneumoencephalographic findings showing a mass extending into the hypothalamus from the sellar region.
The tumour in this patient was shown to be secreting greater than normal amounts of corticotrophin as evidenced by an increase in the plasma cortico-trophin levels. The actual level of plasma corticotrophin (3.3 mU/100 ml) in this case is less than that in the two previously reported patients with primary pituitary tumour with Cushing's syndrome (6 mU) (Simkin et 
